Innate Pharma SA (IPHA) dividend history

IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30

$1.38−0.11 (-7.38%)

Close on Nov 13, 2026Market cap $129.33MP/E –Yield –

Dividends

No dividend per share appears in Innate Pharma's annual filings since fiscal 2016.

Parsed from the XBRL in Innate Pharma's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IPHA.

Revenue growth-55.2% · median -18.4%

Operating margin-599.8% · median -1693.7%

Advertisement
300 × 250

See a number that looks wrong?